Table 2.
Parameter | No.(%) of children hMPV‐positive | No.(%) of children RSV‐positive | No.(%) of children hMPV‐ and RSV‐positive | No.(%) of children hMPV‐ and RSV‐negative | P |
---|---|---|---|---|---|
Median age(months) | 11.5 ± 15.6 | 9.0 ± 9.8 | 8.72 ± 10.3 | 17.1 ± 24.10 | <0.05 a, b |
Age distribution | |||||
<6months | 119/227 (52.4) | 175/313 (55.9) | 54/95 (56.9) | 188/433 (43.4) | <0.05 b |
6 months‐2 years | 72/227 (31.7) | 111/313 (35.5) | 31/95 (32.6) | 148/433 (11.0) | <0.05 b |
2 years‐6 years | 34/227 (15.0) | 27/313 (8.6) | 10/95 (10.5) | 79/433 (18.2) | <0.05 a |
>6 years | 2/227 (0.9) | 0/313 (0) | 0/95 (0) | 18/433 (4.1) | <0.05 b |
Sex | |||||
male | 148/227 (65.2) | 213/313 (68.1) | 57/95 (60) | 285/433 (65.8) | NS |
female | 79/227 (34.6) | 100/313 (31.9) | 38/95 (40) | 148/433 (34.2) | NS |
Clinical sign | |||||
Feverd | 82/227 (36.1) | 121/313 (38.7) | 31/95 (32.6) | 157/433 (36.3) | NS |
cough | 225/227 (99.1) | 311/313 (99.4) | 94/95 (98.9) | 423/433 (97.7) | NS |
wheezing | 167/227 (73.6) | 228/313 (72.8) | 78/95 (82.1) | 225/433 (52.0) | <0.05 b |
cyanosis | 193/227 (85.0) | 279/313 (89.1) | 92/95 (96.8) | 340/433 (78.5) | <0.05 b, c |
respiratory failure | 18/227 (7.9) | 31/313 (9.9) | 11/95 (11.6) | 14/433 (3.2) | <0.05b |
mechanical ventilation | 1/227 (0.4) | 1/313 (0.3) | 0/95 (0) | 1/433 (0.2) | NS |
Lab examination | |||||
WBC >10 × 109/L(num) | 86/224 (38.4) | 113/310 (36.5) | 37/94 (39.4) | 133/421 (31.6) | NS |
CRP > 8mg/L(num) | 15/170 (8.8) | 9/229 (3.9) | 3/72 (4.2) | 34/323 (10.5) | NS |
Hospital stay (days) | 8.0 ± 4.6 | 7.8 ± 4.3 | 7.8 ± 3.2 | 7.3 ± 3.7 | <0.05b |
hMPV: human metapneumovirus; RSV: respiratory syncytial virus; NS: non‐significant; WBC: white blood count; num: numbers; CRP: C‐reative protein.
Comparison of hMPV‐positive to RSV‐positive patients.
Comparison of hMPV‐positive to hMPV and RSV‐negative patients.
Comparison of hMPV‐positive to hMPV and RSV co‐infection patients.
Body temperature of ≥38 °C.